Clinical Trials Directory

Trials / Conditions / Anal Canal Cancer

Anal Canal Cancer

13 registered clinical trials studyying Anal Canal Cancer — 4 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingScreening for Anal Cancer and Precancer in Women With HIV (SANCA)
NCT07059442
Karolinska InstitutetN/A
RecruitingDynamic ctDNA Assessment in Cervical and Anal Canal Tumors: Optimizing Follow-up and Clinical Outcomes
NCT06640283
Instituto do Cancer do Estado de São PauloPhase 2
RecruitingInguinal Node Sparing Radiotherapy For Patients With Early Stage Anal Cancer
NCT05040815
AHS Cancer Control AlbertaPhase 2
UnknownChemoradiotherapy Combined With or Without PD-1 Blockade in Anal Canal Squamous Carcinoma Patients
NCT05374252
Sixth Affiliated Hospital, Sun Yat-sen UniversityPhase 3
CompletedPD-1 Blockade Combined With Chemotherapy Followed by Concurrent Immunoradiotherapy for Locally Advanced SCCA P
NCT05060471
Sun Yat-sen UniversityPhase 2
WithdrawnImmunomonitoring and Biomarker Research in Patients With Squamous Cell Anal Carcinoma
NCT03942900
Centre Hospitalier Universitaire de Besancon—
CompletedCombination of UCPVax Vaccine and Atezolizumab for the Treatment of Human Papillomavirus Positive Cancers (Vol
NCT03946358
Centre Hospitalier Universitaire de BesanconPhase 2
Unknown"Cross" Closure for Reconstructing the Perineal Wound of Abdominoperineal Resection
NCT03731754
Sixth Affiliated Hospital, Sun Yat-sen UniversityN/A
Active Not RecruitingIntratreatment FDG-PET During Radiation Therapy for Gynecologic and Gastrointestinal Cancers
NCT03403465
Duke UniversityPhase 2
RecruitingStereotactic Body Radiation Therapy (SBRT) for Unresectable Liver Metastases
NCT02185443
University of Sao PauloPhase 2
CompletedA Study of Substitution of 5-FU (Fluorouracil) by Capecitabine in Scheme of Chemo-radiotherapy in Patients Wit
NCT01941966
Instituto do Cancer do Estado de São PauloPhase 2
UnknownA Phase II Study to Assess Acute Toxicity and Quality of Life of Patients With Carcinoma of the Anal Canal Rec
NCT00754078
AHS Cancer Control AlbertaPhase 2
CompletedInterstitial Brachytherapy Boost for Treatment of Anal Canal Cancers, Comparison of Two Dose Rates
NCT03465501
Institut Paoli-Calmettes—